Atazanavir sulfate
![Atazanavir sulfate Structure](CAS/GIF/229975-97-7.gif)
- CAS No.
- 229975-97-7
- Chemical Name:
- Atazanavir sulfate
- Synonyms
- Zrivada;Cgp 75355;Aids060276;Aids-060276;BMS-232632-05;BMS232632 sulfate;Atazanavir Sulfate;BMS 232632 sulfate;BMS-232632 sulfate;Atazanavir Sulphate
- CBNumber:
- CB3547456
- Molecular Formula:
- C38H54N6O11S
- Molecular Weight:
- 802.94
- MOL File:
- 229975-97-7.mol
- Modify Date:
- 2024/7/2 8:55:06
Melting point | 195.0°, or acetone; mp 198-199° (dec) |
---|---|
alpha | D22 -46.1° (c = 1 in 1:1 CH3OH/H2O, pH = 2.6) |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | ≥28.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥4.05 mg/mL in EtOH with gentle warming and ultrasonic |
form | Powder |
color | White to light yellow |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() GHS08,GHS05 |
---|---|
Signal word | Danger |
Hazard statements | H372-H318 |
Precautionary statements | P280-P305+P351+P338-P310-P260-P264-P270-P314-P501 |
Safety Statements | 24/25 |
HS Code | 29333990 |
Atazanavir sulfate Chemical Properties,Uses,Production
Description
Atazanavir (BMS-232632, III), an azapeptide HIV protease inhibitor, has been developed and launched by Bristol-Myers Squibb (BMS), under worldwide license from Novartis, for the treatment of HIV infection. Atazanavir was launched in the US as Reyataz™ in July 2003.
Chemical Properties
Off-White Solid
Uses
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM
Atazanavir sulfate Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 286)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
TYNDAL LABS PVT LTD | +91-8008166674 +91-8008166674 | AndhraPradesh, India | 95 | 58 | Inquiry |
CDYMAX | +91-9019317788 +91-9019317788 | Bangalore, India | 28 | 58 | Inquiry |
Gonane Pharma | +91-9819380043 +91-9819380043 | NaviMumbai, India | 192 | 58 | Inquiry |
Apotex Pharmachem India Pvt Ltd | +91-8022891034 +91-8022891000 | Karnataka, India | 109 | 58 | Inquiry |
Lupin Ltd | +91-8019896181 +91-8019896181 | Maharashtra, India | 93 | 58 | Inquiry |
Cipla Ltd | +912224826000 | Maharashtra, India | 133 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Sun Pharmaceutical Industries Ltd | +91-2242244224 +91-2243244324 | Maharashtra, India | 108 | 58 | Inquiry |
Mangalam Drugs and Organics Ltd | +91-2222616300 +91-2222616200 | Maharashtra, India | 37 | 58 | Inquiry |
VIVIN DRUGS AND PHARMACEUTICALS LTD | +91-22670456625 +91-224067045635 | Telangana, India | 22 | 58 | Inquiry |
Supplier | Advantage |
---|---|
TYNDAL LABS PVT LTD | 58 |
CDYMAX | 58 |
Gonane Pharma | 58 |
Apotex Pharmachem India Pvt Ltd | 58 |
Lupin Ltd | 58 |
Cipla Ltd | 58 |
Hetero Drugs Limited | 58 |
Sun Pharmaceutical Industries Ltd | 58 |
Mangalam Drugs and Organics Ltd | 58 |
VIVIN DRUGS AND PHARMACEUTICALS LTD | 58 |
229975-97-7(Atazanavir sulfate)Related Search:
chevron_left
1of4
chevron_right
1-(4-Biphenylyl)-4(S)-hydroxy-5(S)-2,5-bis{[N-(methoxycarbonyl-)-L-tert-leucinyl]amino}-6-phenyl-2-azahexane
Aids060276
Aids-060276
Cgp 75355
Methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(Methoxycarbonyl)aMino]-3,3-diMethyl-N'-{[4-(pyridin-2-yl)phenyl]Methyl}butanehydrazido]-1-phenylbutan-2-yl]carbaMoyl}-2,2-diMethylpropyl]carbaMate
Atazanavir sulfate (BMS-232632-05)
BMS-232632-05
Zrivada
(3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid 1,14-dimethyl ester, sulfate (1:1)
methyl((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamatesulfate
Atazanavir Sulfate
Atazanavir Sulphate
Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate
N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-1-oxobutyl]amino]-4-phenylbutyl]-2-[(4-phenylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamic acid methyl
BMS 232632 sulfate
BMS 232632 SULFATE;BMS-232632 SULFATE;BMS232632 SULFATE
BMS232632 sulfate
BMS-232632 sulfate
Atazanavir sulfate, 99%, HIV protease inhibitors
Atazanavir (BMS-232632) sulfate
Methyl {(5S,10S,11S,14S)-11-benzyl-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-8-[4-(2-pyridinyl)benzyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl}carbamate
ATAZANAVIR SULFATE (BMS-232632 SULFATE)
Atazanavir sulfate CRS
((5S,6S)-5-hydroxy-1,8-dioxo-6-(phenyl methyl)-3-[[4-(2-
pyridinyl)phenyl]methyl] -2,3,7 triaza octane dioic acid
tertiary butyl ester)
Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate
Atazanavir sulfate USP/EP/BP
Atazanavir Sulfate (Latazanavir, Zrivada, Reyataz, BMS232632)
Atazanavir sulfateQ: What is
Atazanavir sulfate Q: What is the CAS Number of
Atazanavir sulfate Q: What is the storage condition of
Atazanavir sulfate Q: What are the applications of
Atazanavir sulfate
Atazanavir Sulfate (1044334)
229975-97-7
C38H52N6O7H2SO4
Inhibitor
Atazanavir
Antiviral Agents
Inhibitors
peptides
BMS-232632-05, Reyataz
229975-97-7